Skip to main content

Table 5 Treatment outcomes among the studied groups according to RT-PCR results

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Treatment outcomes Total cases (No. = 280) Total (n = 280) χ2 test and P value
Group I (n = 140), Group II (n = 80) Group III (n = 60),
No. % No. % No. % No. %
Responder/SVR (No. = 260) 130 92.9 70 87.5 60 100 260 92.9 Test = 3.56
P = 0.47
Non-responder (No. = 10) 10 7.1 0 0.0 0 0.0 10 3.6
Relapse (No. = 10) 0 0.0 10 12.5 0 0.0 10 3.6